摘要：FDA日前批准首个依诺肝素钠注射剂仿制药用于预防深度静脉血栓形成。依诺肝素钠注射剂于1993年获批，依诺肝素钠由肝素制成，其活性成分是一种天然衍生的复杂糖分子。
注：因版权方要求，不能公开全文，如需全文，请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering